NCT00425971View on ClinicalTrials.gov

Safety Study of Anti-Asthma Agent BMEC-1217B

PHASE1UnknownINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 31, 2008

Conditions
Asthma
Interventions
DRUG

BMEC-1217B

Trial Locations (1)

114

RECRUITING

Tri-Service General Hospital, Taipei

Sponsors
All Listed Sponsors
lead

Medigreen Biotechnology Corp.

INDUSTRY